Sign In
to Vote &
Create Storyboards.
 
For patient safety, the US Food and Drug Administration should require that clinical data be submitted as part of a more rigorous re-evaluation of medical devices that are modified after approval. According to authors of a new expert opinion, such a requirement could prevent deaths due to insufficiently tested device modifications.
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard